| DVN |
Report |
Adjusted EPS |
BEAT |
pred ~$1.45 vs. cons ~$1.32 |
MEDIUM |
| DVN |
Report |
Total Revenue |
BEAT |
pred ~$6.65B vs. cons ~$6.30B |
MEDIUM |
| DVN |
Report |
Total Production (boe/d) |
BEAT |
pred ~1.36 mmboe/d vs. cons ~1.34 mmboe/d |
MEDIUM |
| DVN |
Guide |
FY2026 Production Guidance |
BETTER |
guide ~1.39 mmboe/d vs. cons ~1.38 mmboe/d (FY2026) |
MEDIUM |
| DVN |
Guide |
FY2026 Capex Guidance |
BETTER |
guide ~$4.85B vs. cons ~$4.90B (FY2026) |
MEDIUM |
| DVN |
Guide |
Coterra Synergy Run-Rate Capture |
BETTER |
guide ~$350M captured to date vs. cons ~$200M expected (as of Q2 2026, toward $1B YE2027 target) |
LOW |
| DVN |
Guide |
Portfolio Divestiture Announcement (Eagle Ford/Powder River) |
BETTER |
guide ~$4.0B proceeds/strategic review announced vs. cons ~$0B formal announcement expected (2026) |
MEDIUM |
| DVN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| DVN |
Return |
5-day cumulative residual |
+5.0% (FOLLOW-THROUGH) |
A clean EPS/production beat on strong Q2 oil realizations (mirroring XOM/CVX/FANG's best profits in years) plus a concrete Eagle Ford/Powder River divestiture announcement and quantified synergy progress should prompt sell-side estimate and price-target increases through the week, easing activist pressure (Kimmeridge/Toms Capital) and supporting follow-through even if crude gives back some gains on Iran de-escalation headlines; residual gains build modestly as the divestiture/synergy narrative gets priced in over the debt-paydown and buyback commentary. |
LOW |